NFA
AVEO

Nationwide Fund Advisors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Nationwide Fund Advisors’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-4,046
Closed -$74K – 3243
2013
Q4 		$74K Sell
4,046
-125
-3% -$2.5K ﹤0.01% 3021
2013
Q3 		$86K Buy
4,171
+508
+14% +$11.6K ﹤0.01% 2974
2013
Q2 		$92K Buy
+3,663
New +$157K ﹤0.01% 2831

Other funds holding AVEO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nationwide Fund Advisors's AVEO Position: Q1 2014 in Review

Nationwide Fund Advisors sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2014, closing a stake of 4,046 shares — an estimated $74K sold.

Nationwide Fund Advisors first reported a position in AVEO in Q2 2013 and held it in 3 quarters. The position peaked at $92K in Q2 2013. 68 funds tracked by Wall St. Rank hold AVEO as of Q1 2014.

  • Nationwide Fund Advisors reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2014 after selling out during the quarter.
  • Nationwide Fund Advisors sold 4,046 AVEO Pharmaceuticals, Inc. shares in Q1 2014, an estimated $74K.
  • Nationwide Fund Advisors first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 3 quarters.
  • Nationwide Fund Advisors's AVEO Pharmaceuticals, Inc. position peaked at $92K in Q2 2013.
  • 68 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2014.

Based on Nationwide Fund Advisors's 13F filing for Q1 2014, filed 9 May 2014.